Loading...
Loading...
GBIO| Name | Value |
|---|---|
| Revenues | 7.6M |
| Cost of Revenue | 0.0M |
| Gross Profit | 7.6M |
| Operating Expense | 25.4M |
| Operating I/L | -17.9M |
| Other Income/Expense | 2.6M |
| Interest Income | 2.6M |
| Pretax | -15.3M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -15.3M |
Generation Bio Co. is a genetic medicines company specializing in the development of therapies for rare and prevalent diseases. The company's portfolio includes programs for diseases of the liver, retina, skeletal muscle, central nervous system, and oncology. By focusing on genetic medicines, Generation Bio Co. aims to provide innovative treatments for a wide range of medical conditions, catering to both rare and prevalent diseases. The company's revenue is generated through the development and commercialization of these genetic therapies, offering potential solutions for patients in need of advanced medical interventions.
